 Home > Medical News > Medicines Company News > Proton Biotech announced that it has reached a strategic cooperation with Kaidi Biotech to accelerate the development and production of CAR-T drugs

Proton Biotech announced that it has reached a strategic cooperation with Kaidi Biotech to accelerate the development and production of CAR-T drugs

 Last Update: 2021-07-06
 Source: Internet
 Author: User

Tags

ascites cancer

shin cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On May 31, 2021, Suzhou Boten Biopharmaceutical Co.
, Ltd.
(hereinafter referred to as Boten Bio) announced that it has reached a strategic cooperation with Nanjing Kaidi Biotechnology Co.
, Ltd.
(hereinafter referred to as Kaidi Bio)
.

With an end-to-end gene and cell therapy CDMO service platform, Proton Bio provides CMC research and development services for Kaidi Bio's new CAR-T cell therapy, and accelerates the development of cell therapy drugs

According to the agreement, Proton Bio will serve as the exclusive CDMO partner to provide CMC research and development services for multiple CAR-T projects, including the process development and production of plasmids, viral vectors and CAR-T cells, and the IND registration of the CMC part.
Declaration support and other services
.

The first collaborative project KD-025 CAR-T product is indicated for liver cancer and glioma.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.